FinTrust Capital Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.73K Sell
473
-77
-14% -$1.09K ﹤0.01% 1025
2024
Q2
$7.12K Buy
550
+147
+36% +$1.95K ﹤0.01% 970
2024
Q1
$5.6K Sell
403
-118
-23% -$1.72K ﹤0.01% 967
2023
Q4
$7.43K Hold
521
﹤0.01% 883
2023
Q3
$8.06K Sell
521
-114
-18% -$1.76K ﹤0.01% 817
2023
Q2
$9.91K Hold
635
﹤0.01% 771
2023
Q1
$9.91K Hold
635
﹤0.01% 769
2022
Q4
$9.91K Sell
635
-15
-2% -$210 ﹤0.01% 766
2022
Q3
$8K Hold
650
﹤0.01% 940
2022
Q2
$9K Hold
650
﹤0.01% 921
2022
Q1
$10K Sell
650
-177
-21% -$2.6K ﹤0.01% 954
2021
Q4
$11K Sell
827
-120
-13% -$1.68K ﹤0.01% 903
2021
Q3
$16K Sell
947
-11
-1% -$185 ﹤0.01% 797
2021
Q2
$16K Sell
958
-89
-9% -$1.51K ﹤0.01% 812
2021
Q1
$19K Hold
1,047
0.01% 736
2020
Q4
$19K Buy
1,047
+193
+23% +$3.39K 0.01% 697
2020
Q3
$15 Hold
854
﹤0.01% 716
2020
Q2
$15K Sell
854
-99
-10% -$1.78K 0.01% 678
2020
Q1
$14K Sell
953
-234
-20% -$4.24K 0.01% 701
2019
Q4
$23K Buy
1,187
+61
+5% +$1.17K 0.01% 607
2019
Q3
$19K Buy
1,126
+68
+6% +$1.18K 0.01% 665
2019
Q2
$19K Sell
1,058
-157
-13% -$2.86K 0.01% 621
2019
Q1
$25K Buy
1,215
+468
+63% +$9.42K 0.01% 547
2018
Q4
$13K Buy
+747
New +$12.6K 0.01% 708

Other funds holding TAK